"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves endoscopy, imaging, laparoscopy, and molecular testing for markers like HER2 ...

Stomach cancers are increasingly being diagnosed at less advanced, more treatable stages - a shift that marks major progress in detecting one of the deadliest forms of cancer, according to a study to ...

Early-onset gastrointestinal (GI) cancers are climbing among those younger than 50 years, in the US and globally. Although colorectal cancer accounts for approximately half of such cases, rates are ...

Gastric cancer is the third leading cause of cancer-related deaths worldwide, mainly due to delayed diagnosis. Globally, more than 60% of gastric cancer cases are diagnosed at advanced stages, when ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

Blood type is usually treated like a background detail. Something written on hospital files, checked once, then forgotten. It ...

The annual cancer statistics report from the National Cancer Institute (NCI) — which was published in the journal Cancer on Monday, April 21 — shows some signs of progress in America’s fight against ...